<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
  <url>
    <loc>https://www.law360.com/health/articles/1528/appeals-court-bars-andrx-from-using-altotocor-brand-name?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-09T01:00:55Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1527/andrx-relinquishes-exclusivity-rights-to-150mg-generic-zyban-?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T11:41:33Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1516/ftc-oks-bristol-myers-teva-deal-on-paraplatin?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T20:07:07Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1512/nih-hears-arguments-over-compulsory-license-for-aids-drug?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T22:29:57Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1507/altana-files-patent-suit-vs-teva-over-anti-ulcer-drug?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T20:07:06Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1508/glaxosmithkline-to-pay-75m-to-settle-patent-suit?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-09T16:50:05Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1506/medtronic-units-infringed-interpore-cross-patent-court-finds?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T17:50:42Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1488/u-s-district-court-judge-issues-permanent-injunction-vs-ventana?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-09T16:21:08Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1491/teva-to-continue-selling-generic-vicoprofen-after-losing-vs-abbott-at-federal-circuit?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T18:46:01Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1486/nyc-files-antitrust-suit-vs-glaxo-over-paxil-patents?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T20:13:29Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1485/epo-revokes-controversial-patent-for-breast-cancer-screening?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T12:38:31Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1473/purdue-to-hold-off-on-oxycontin-generics-until-federal-circuit-ruling?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T21:55:18Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1479/court-rejects-motion-to-declare-roche-dna-replication-technology-patents-unenforceable?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T16:26:27Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1467/court-strips-b-braun-of-key-patent-in-dispute-with-inventor?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T18:59:55Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1464/canada-passes-law-authorizing-generic-drug-exports?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T11:41:32Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1453/abbott-faces-calls-for-compulsory-license-for-norvis?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-09T18:26:22Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1450/canada-to-pass-generics-bill-friday?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T13:29:12Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1436/federal-circuit-rules-for-elan-in-naproxen-patent-suit?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T20:51:49Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1430/cephalon-plans-to-file-patent-suit-vs-sandoz-over-provigil-anda?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T12:38:30Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1424/global-generic-drug-market-to-grow-10-15-annually-survey-says?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-09T19:49:52Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1416/phrma-urges-fda-to-flesh-out-medicare-act-provisions-on-180-day-exclusivity?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-09T17:44:20Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1409/canada-set-to-ok-patent-law-amendments-this-week?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-09T11:42:06Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1398/pfizer-sues-websites-for-selling-illegal-lipitor-generic?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-06-12T18:06:02Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1400/repligen-mit-sue-imclone-over-erbitux-patent?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-09T07:58:50Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1407/genentech-asks-fda-to-hold-off-biogenerics-policy-paper?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T23:56:17Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1406/poverty-not-patents-greatest-barrier-to-drug-access-for-poor-study-finds?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-08T22:57:51Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.law360.com/health/articles/1396/judge-denies-request-to-dismiss-patent-challenge-vs-glaxo-s-azt?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=section_archive</loc>
    <lastmod>2026-07-09T12:49:35Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
</urlset>
